Chrenek Peter, Vasicek Dusan, Makarevich Alexander V, Jurcik Rastislav, Suvegova Karin, Parkanyi Vladimir, Bauer Miroslav, Rafay Jan, Batorova Angelika, Paleyanda Rekha K
Research Institute of Animal Production, Hlohovská 2, 949 92 Nitra, Slovak Republic.
Transgenic Res. 2005 Aug;14(4):417-28. doi: 10.1007/s11248-005-3238-8.
Transgenic rabbits provide a useful biological model for the study of the regulation of mammalian genes. However, transgene integration efficiency has generally been low. Here we present a first attempt to increase the integration rate of exogenous DNA into the rabbit genome, using a double pronuclei microinjection method. Pronuclear stage rabbit embryos were recovered from superovulated NZW females, 19-20 h after hCG injection. About 5 microg/mL of exogenous DNA solution was microinjected either into one pronucleus (single microinjection, SM) or into both pronuclei (double microinjected, DM). The transgene consisted of a 2.5 kb murine whey acidic protein promoter (mWAP), 7.2 kb cDNA of the human clotting factor VIII (hFVIII), and 4.6 kb that of 3' flanking sequences of the mWAP gene. The in vitro survival of DM embryos to the blastocyst stage was lower than that of SM embryos (68 vs. 89%). Similar results were obtained using EGFP as a control gene construct. However, there was no difference in the percentage of embryos that developed into live offspring using DM (25%) vs. SM (26%). The integration frequency of mWAP-hFVIII into the genome of transgenic rabbits was 3.3% (1/30) upon SM and 8.1% (4/49) at DM (p < 0.05). All founders transmitted the transgene to their offspring in a Mendelian fashion. The SM founder female secreted 87.4 microg/mL rhFVIII in milk, with an activity of 0.594 IU/mL. The DM founder female produced 118 microg/mL rhFVIII, with activity values of 18 IU/ mL. This is the first report of transgenic rabbit production using a double microinjection technique. Our preliminary results suggest that this method can increase the efficiency of production of transgenic rabbit founders, giving a higher integration rate than single microinjection.
转基因兔为研究哺乳动物基因调控提供了一个有用的生物学模型。然而,转基因整合效率通常较低。在此,我们首次尝试使用双原核显微注射法提高外源DNA整合到兔基因组中的速率。在注射人绒毛膜促性腺激素(hCG)后19 - 20小时,从超排卵的新西兰白兔(NZW)母兔中回收原核期兔胚胎。将约5微克/毫升的外源DNA溶液显微注射到一个原核(单显微注射,SM)或两个原核中(双显微注射,DM)。转基因由一个2.5千碱基对(kb)的小鼠乳清酸性蛋白启动子(mWAP)、7.2 kb的人凝血因子VIII(hFVIII)cDNA以及4.6 kb的mWAP基因3'侧翼序列组成。DM胚胎体外发育到囊胚期的存活率低于SM胚胎(分别为68%和89%)。使用绿色荧光蛋白(EGFP)作为对照基因构建体也获得了类似结果。然而,使用DM(25%)与SM(26%)发育成活后代的胚胎百分比没有差异。mWAP - hFVIII整合到转基因兔基因组中的频率在SM时为3.3%(1/30),在DM时为8.1%(4/49)(p < 0.05)。所有转基因奠基动物均以孟德尔方式将转基因传递给其后代。SM转基因奠基母兔乳汁中分泌的重组人凝血因子VIII(rhFVIII)为87.4微克/毫升,活性为0.594国际单位/毫升。DM转基因奠基母兔产生的rhFVIII为118微克/毫升,活性值为18国际单位/毫升。这是关于使用双显微注射技术生产转基因兔的首次报道。我们的初步结果表明,该方法可以提高转基因兔奠基动物的生产效率,比单显微注射具有更高的整合率。